Description

Greatbatch, Inc. (GB) is engaged in the business of medical devices manufacturing. The company along with subsidiaries specializes in the business line of developing, manufacturing and designing of components for implantable medical devices under the brand name of ViaPeel FlowGuard. The company by and large operates in implantable medical components (IMC) segment and electrochem commercial power (ECP) segment. The company’s product portfolio consists of cardiac rhythm management devices, catheter delivery systems, electrochem commercial power products and others. The company principally operates in the regions of US and Ireland.

Global Markets Direct’s Greatbatch, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Greatbatch, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.